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1. Introduction 
In the small intestine of rats, rabbits or hamsters 
L-ascorbate is taken up by a lowcapacity, Na+-inde- 
pendent system showing ‘diffusion’ kinetics ([l-4] 
and Caspary, unpublished quoted [5]). In at least two 
of the mammalian species in which this substance is a 
vitamin, viz., man and the guinea pig, L-ascorbate is 
taken up by a saturable system of larger capacity 
which is activated by extracellular Na+ [5-71. 
In the guinea pig, we have recently shown that L- 
ascorbate transport into brush border membrane vesi- 
cles is not due to the system(s) transporting D-glu- 
cose. It is carrier-mediated and electrically neutral 
with an L-ascorbate:Na+ flux ratio of 1. The epimer 
of L-ascorbate in C5, erythorbate (D-isoascorbate) 
was found to be transported by the same system as 
Lascorbate, thus acting as a (weak) fully-competitive 
inhibitor (Ki N 18 mM, as compared with the Km for 
L-ascorbate, 0.3 mM) [4]. 
In man, to the best of our knowledge, few kinetic 
studies in vitro have been performed. In particular, no 
investigation up to now has utilized brush border 
membrane vesicles, which are the only preparation 
capable of providing unequivocal information as to 
the type of transport system involved. Yet in man it 
is particularly important to closely scrutinize the in- 
teraction of erythorbate with the transport system 
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for L-ascorbate since: 
(i) Population groups may derive their daily intake 
of L-ascorbate mainly from the ascorbate present 
as an additive to foodstuffs [8]; 
(ii) Erythorbate, which is indeed absorbed in human 
intestine [9], is being used in some countries as 
an additive to foodstuffs for technological rea- 
sons; 
(iii) Erythorbate and L-ascorbate compete for the 
same membrane transport systems in peripheral 
tissues (e.g. [IO]). 
The major difficulty in working with man is, of 
course, that of obtaining sufficient amounts of suit- 
able material. In fact, for uptake studies of this kind, 
neither peroral biopsies (too small) nor post-mortem 
material (quickly degraded) are adequate. 
Our studies in man, therefore, were perforce less 
extended than those in the guinea pig [4]. The results 
below do show, however, that the L-ascorbate trans- 
port systems in the small intestinal brush border 
membranes of the two species are similar. In man the 
system also: 
(i) Shows saturation by the substrate; 
(ii) Is activated by external Na’; 
(iii) Is electroneutral (and can thus be expected to 
have a L-ascorbate:Na+ flux ratio of 1); 
(iv) Is not identical with the system(s) transporting 
D-glucose; 
(v) Is inhibited fully-competitively by D-erythorbate 
(probably a substrate for the system). 
Judging from the estimated Km- and Ki-values, cry- 
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Table 1 
Dependence of L-ascorbate uptake on the time of incubation - Inhibition by D-isoascorbate (D-erythorbate) 
Incubation 
time (mitt) 
L-Ascorbate concentrations 
(mM) yielding half-maximum 
uptake (X f- SE) 
L-Ascorbate uptake at 
infinitely large L- 
ascorbate concentration 
(pmot . mg protein-‘) (2 * SE) 
Apparent Ki- 
value for D- 
isoascorbate (mM) 
1 0.20 f 0.127 254 + 45 11 
1.5 0.432 i 0.22 366 + 83 13 
2 0.489 f 0.07 521 f 38 38 
Brush border membrane vesicles from human jejunum were incubated at 20°C with various concentrations of L-(“Clascorbate 
(0.3,0..5,0.7 or 1 .O mM) in 300 mM D-mannitoi, 10 mM Hepes/Tris (pH 7.5) with an initial Na,SO, gradient (50 mM out, 0 in). 
The app. Ki-v&es were estimated from Dixon plots similar to those of fig.1 
- 1.0 mM L- Ascorbate 
t 
Ki =11 mM 
0 
I I I 
lo 20 30 mM 
D- lsoascorbate 
F&l. Dixon plot of the inhibition of L-ascorbate uptake into brush border membrane vesicles by D-isoascorbate (D-erythorbate). 
Sixty-second L-ascorbate uptake was measured at 20°C in the presence of an initial Na,SO, gradient (50 mM out, 0 in) and the 
indicated concentrations of L-j “CJascorbate and D-isoascorbate. The buffer was in all cases 10 mM Hepeq’Tris (pH 7.5) plus 
300 mM D-mannitol. The arrow indicates the reciprocal of the L-ascorbate concentration (mM) giving maximum uptake (60 s), as 
calculated from double-reciprocal plots in parallel experiments. 
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thorbate must inhibit Lascorbate uptake in human 
small intestine at least as much as it does in the 
guinea pig. 
2. Materials and methods 
Macroscopically normal pieces of human jejunum 
or ileum were obtained during operations on the 
small bowel and were kept at -20°C for no longer 
than a couple of weeks. After thawing, brush border 
membrane vesicles were prepared via Ca* precipita- 
tion ([ 1 l] as modified in [ 121). The uptake of 
L-[ 14C] ascorbate into these vesicles was measured at 
20°C in 10 mM Hepes/Tris (pH 7.5) 100 mM D-man- 
nitol, plus the salts and at the ascorbate concentra- 
tion(s) indicated in the legends to the figures. The 
incubations were stopped by addition of ice-cold 
250 mM NaCl, the suspension filtered through a 
Sartorius filter (0.6 pm pore size) under suction, and 
washed once with the same ice-cold solution. The 
radioactivity in the filter was measured in a scintilla- 
tion counter. For details, refer to [4]. 
3. Results and discussion 
In man, as in the guinea pig [4], the capacity of L- 
ascorbate transport is too low (and not compensated 
for by a particularly high specific radioactivity of the 
substrate available) to allow determination of Km- 
and Ki-values from the short initial linear uptake 
(discussed in [13,14]). We thus resorted to estimating 
them from incubations as short as possible (table 1, 
and fig.1). Clearly, the transporter for L-ascorbate 
shows saturation and fully-competitive inhibition by 
D-erythorbate. The latter phenomenon is most likely 
due to this substance being transported by the same 
system: in guinea pig small intestinal vesicles erythor- 
bate elicits counterflow of L-ascorbate [4]. L-Ascor- 
bate transport is activated by extravesicular Na+ (com- 
pare the 60 s uptake values in Na2S04 and NaNOa 
with those in KzS04 and KNOa, respectively, in the 
lower panel of fig.2). 
Contrary to the transport of D-glucose in the same 
preparation (upper panel of fig.2) (see also [ 12,15]), 
that of L-ascorbate is insensitive to differences in the 
electric potential, as induced by highly permeant 
Fig.2. Lower panel: effects of cations and anions on 
L-[ “Clascorbate uptake. The initial concentrations in the 
incubation media were: L-[!‘C]ascorbate, 0.5 mM; buffer 
and D-mannitol, as in fig.1; salts: Na,SO,, K,SO, or CaCl,, 
50 mM; NaNO,, Na cyclamate, NaN, or KNO,, 100 mM. 
Upper panel: In the same vesicles under similar conditions 
D-glucose uptake was electrogenic. D-[3H]Glucose (5 PM) 
uptake was measured in the presence of either a NaSCN 
gradient (100 mM out, 0 in) ( -), or a Na,SO, gradient 
(50 mM out, 0 in) (---). The uptake in the presence of a 
NaNO, gradient was the same as in the presence of a NaSCN 
gradient (data not shown). Other conditions, as in the exper- 
iment of the lower panel. 
anions (e.g., NO; or NJ) compared with relatively im- 
permeant ones (e.g., SOi- or cyclamate) (lower panel 
in fig.2). Thus, on the basis of the criteria discussed 
elsewhere (e.g. in table 2 of [4]), the electroneutral 
Na+-dependent L-ascorbate transport in human small 
intestine also is due to a L-ascorbate, Na+-cotransport- 
ing carrier with (under the experimental conditions 
used here) a flux ratio of 1. 
The system for L-ascorbate transport is not iden- 
tical with that mediating D-glucose transport because: 
6) 
(ii) 
Phlorizin, a strong fully-competitive inhibitor of 
intestinal D-glucose transport (e.g. [13,16]) does 
not detectably inhibit (-3% + 9%) L-ascorbate 
uptake at concentrations (0.25 mM) which 
strongly inhibit D-glucose uptake; 
L-Ascorbate does not inhibit D-glucose uptake 
(data not shown); 
(iii) D-Glucose only marginally inhibits L-ascorbate 
uptake (data not shown). (Presumably an exam- 
ple of heterologous inhibition [4]). 
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Summing up, L-ascorbate transport across small 
intestinal brush border membranes is very similar in 
man and in guinea pig, and is quite different from 
that in rat, hamster or rabbit. In the last 3 species it is 
Na’-insensitive and has the kinetic characteristics of a 
‘diffusion’ [l-5]. It is well known, of course, that 
man and guinea pig belong to the few mammalian 
species which are unable to carry out the complete 
synthesis of L-ascorbate and for which this substance 
is thus a vitamin. The possible nutritional relevance of 
the inhibition of L-ascorbate uptake by D-erythor- 
bate is difficult to assess from in vitro experiments. 
The maximum accepted daily intake of this inhibitor 
(as high as 5 mg/Kg body wt in some countries), the 
amount of L-ascorbate occurring in the diet and the 
Ki of the fully-competitive inhibition by D-erythor- 
bate (-11 mM) are the main factors which can be ex- 
pected to play a role. 
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